Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II/III Study of Cabazitaxel Versus Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium

NCT01830231 is registered in ClinicalTrials.gov with Associació per a la Recerca Oncologica, Spain as lead sponsor.

NCT NCT01830231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II/III Study of Cabazitaxel Versus Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium
Lead sponsor
Associació per a la Recerca Oncologica, Spain
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 31, 2012
Completion date
November 30, 2016
Enrollment
372 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

urothelium transitional cell carcinoma